{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11861377", "DateCompleted": {"Year": "2002", "Month": "03", "Day": "27"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0008-5472", "JournalIssue": {"Volume": "62", "Issue": "4", "PubDate": {"Year": "2002", "Month": "Feb", "Day": "15"}}, "Title": "Cancer research", "ISOAbbreviation": "Cancer Res"}, "ArticleTitle": "Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells.", "Pagination": {"StartPage": "1025", "EndPage": "1029", "MedlinePgn": "1025-9"}, "Abstract": {"AbstractText": ["Medicinal plants contain pharmacological substances including flavonoids, and their extracts have been therapeutically administered for cancer therapy in vitro and in vivo. We investigated the efficacy of a polymethoxy flavonoid, nobiletin, from Citrus depressa on tumor invasion in vitro. Nobiletin inhibited the tumor-invasive activity of human fibrosarcoma HT-1080 cells in the Matrigel model, whereas a similar inhibition was observed upon exogenously adding tissue inhibitors of metalloproteinases (TIMPs)-1 and -2. The gene expression and production of pro-matrix metalloproteinase 9 (proMMP-9)/progelatinase B and proMMP-1/interstitial procollagenase were specifically suppressed by nobiletin in 12-O-tetradecanoylphorbol 13-acetate-stimulated HT-1080 cells. In contrast, the gene expression and production of TIMP-1, but not TIMP-2, were enhanced by nobiletin. We also demonstrated that nobiletin suppressed the 12-O-tetradecanoylphorbol 13-acetate-induced binding activity of activator protein-1. Furthermore, a phosphatidylinositol 3-kinase inhibitor, LY-294002, was found to mimic the different actions of nobiletin on the production of proMMP-9 and TIMP-1. These results suggest that nobiletin inhibits tumor cell invasive activity not only by suppressing the expression of MMPs but also augmenting TIMP-1 production in tumor cells, and that the nobiletin-mediated inhibition of activator protein-1 binding activity is at least partly involved in the suppression of MMP expression. Furthermore, we suggest a possible mechanism by which nobiletin may interfere in the phosphatidylinositol 3-kinase pathway, which divergently regulates the production of MMP and TIMP-1."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Tokyo University of Pharmacy and Life Science, School of Pharmacy, Hachioji, Tokyo 192-0392, Japan. satotak@ps.toyaku.ac.jp"}], "Identifier": [], "LastName": "Sato", "ForeName": "Takashi", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koike", "ForeName": "Leona", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Miyata", "ForeName": "Yoshiki", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hirata", "ForeName": "Michiko", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mimaki", "ForeName": "Yoshihiro", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sashida", "ForeName": "Yutaka", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yano", "ForeName": "Masamichi", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ito", "ForeName": "Akira", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cancer Res", "NlmUniqueID": "2984705R", "ISSNLinking": "0008-5472"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticarcinogenic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromones"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Matrix Metalloproteinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Morpholines"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphoinositide-3 Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Tissue Inhibitor of Metalloproteinase-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor AP-1"}, {"RegistryNumber": "31M2U1DVID", "NameOfSubstance": "2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one"}, {"RegistryNumber": "D65ILJ7WLY", "NameOfSubstance": "nobiletin"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "Matrix Metalloproteinase 9"}, {"RegistryNumber": "EC 3.4.24.7", "NameOfSubstance": "Matrix Metalloproteinase 1"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anticarcinogenic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chromones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["enzymology", "metabolism", "pathology"], "DescriptorName": "Fibrosarcoma"}, {"QualifierName": [], "DescriptorName": "Flavones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Matrix Metalloproteinase 1"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Matrix Metalloproteinase 9"}, {"QualifierName": [], "DescriptorName": "Matrix Metalloproteinase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Morpholines"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Neoplasm Invasiveness"}, {"QualifierName": [], "DescriptorName": "Phosphoinositide-3 Kinase Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Tissue Inhibitor of Metalloproteinase-1"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Transcription Factor AP-1"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "2", "Day": "28", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "3", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "2002", "Month": "2", "Day": "28", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11861377"]}}], "PubmedBookArticle": []}